148 related articles for article (PubMed ID: 5329243)
1. Effects of anticancer drugs on biochemical control mechanisms.
Henderson JF
Prog Exp Tumor Res; 1965; 6():84-125. PubMed ID: 5329243
[No Abstract] [Full Text] [Related]
2. [In vitro estimation of individual tumor sensitivity to anticancer agents in order to follow surgery with specific cytotoxic therapy].
Kummer D
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1971; 76(2):124-39. PubMed ID: 4255596
[No Abstract] [Full Text] [Related]
3. Mechnaism of action of anticancer drugs at a cellular level.
Karnofsky DA
CA Cancer J Clin; 1968; 18(4):232-4. PubMed ID: 4992875
[No Abstract] [Full Text] [Related]
4. [Specific histotropism of antineoplastic agents].
Berti T
Clin Ter; 1970 Nov; 55(4):293-303. PubMed ID: 4930868
[No Abstract] [Full Text] [Related]
5. The action of antimetabolites and biological alkylating agents on the synthesis of deoxyribonucleic acid and a possible relation between the mechanisms of action.
TIMMIS GM
Biochem Pharmacol; 1960 Aug; 4():49-56. PubMed ID: 13776952
[No Abstract] [Full Text] [Related]
6. Metabolic conditioning and metabolic actuation: experimental approaches to cancer chemotherapy involving combinations of metabolites and antimetabolites.
Bloch A
Cancer Chemother Rep; 1974; 58(4):471-7. PubMed ID: 4853172
[No Abstract] [Full Text] [Related]
7. Pyrimidine metabolism in man. V. The measurement in vivo of the biochemical effect of antineoplastic agents in animal and human subjects.
RABKIN MT; FREDERICK EW; LOTZ M; SMITH LH
J Clin Invest; 1962 Apr; 41(4):871-83. PubMed ID: 14489640
[No Abstract] [Full Text] [Related]
8. [The influence of some alkylating antiblastic drugs and antimetabolites on the healing process of fracture foci. (Experimental research)].
Mangione F; Taverna L
Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1711-2. PubMed ID: 5877911
[No Abstract] [Full Text] [Related]
9. [Drug therapy of cancer].
Brux Med; 1974 Oct; 54(10):583-92. PubMed ID: 4434239
[No Abstract] [Full Text] [Related]
10. The effect of drugs on the oxygen uptake of cells from patients with chronic granulocytic leukaemia.
Antonas KN; Onesti P; Woodliff HJ
Aust J Exp Biol Med Sci; 1965 Dec; 43(6):751-60. PubMed ID: 5220455
[No Abstract] [Full Text] [Related]
11. Effect of DNA repair deficiencies on the cytotoxicity of drugs used in cancer therapy - a review.
Calderón-Montaño JM; Burgos-Morón E; Orta ML; López-Lázaro M
Curr Med Chem; 2014; 21(30):3419-54. PubMed ID: 24934343
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of nitroso chemical carcinogen activation of rat hepatic guanylate cyclase by anticancer agents.
Vesely DL; Levey GS
Oncology; 1979; 36(3):122-6. PubMed ID: 38420
[TBL] [Abstract][Full Text] [Related]
13. Screening of immunosuppressive drugs in the allotransplantation reaction between mice differing at the H-3 locus.
Nouza K
Folia Biol (Praha); 1966; 12(4):266-77. PubMed ID: 5330212
[No Abstract] [Full Text] [Related]
14. Signalling pathways as targets for anticancer drug development.
Powis G
Pharmacol Ther; 1994; 62(1-2):57-95. PubMed ID: 7991648
[TBL] [Abstract][Full Text] [Related]
15. A new class of antimetabolites: pyridine thioglycosides as potential anticancer agents.
Elgemeie GH; Mahdy EM; Elgawish MA; Ahmed MM; Shousha WG; Eldin ME
Z Naturforsch C J Biosci; 2010; 65(9-10):577-87. PubMed ID: 21138059
[TBL] [Abstract][Full Text] [Related]
16. [The effect of various cytostatic drugs on the growth of 12 chosen mycobacterial strains].
Schwartz E
Prax Pneumol; 1971 May; 25(5):278-86. PubMed ID: 5556356
[No Abstract] [Full Text] [Related]
17. Inhibition of the primary immune response in man by anti-metabolites.
Hersh EM; Carbone PP; Wong VG; Freireich EJ
Cancer Res; 1965 Aug; 25(7):997-1001. PubMed ID: 5843275
[No Abstract] [Full Text] [Related]
18. A novel approach to develop anti-HIV drugs: adapting non-nucleoside anticancer chemotherapeutics.
Sadaie MR; Mayner R; Doniger J
Antiviral Res; 2004 Jan; 61(1):1-18. PubMed ID: 14670589
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of cytotoxic agents.
Connors TA
Trans St Johns Hosp Dermatol Soc; 1970; 56(2):100-5. PubMed ID: 5516347
[No Abstract] [Full Text] [Related]
20. [Anticancer drugs and pharmacologic actions].
Ogawa M
Nihon Rinsho; 1997 May; 55(5):1017-23. PubMed ID: 9155146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
